Status:
COMPLETED
Impact of a Regional Antimicrobial Stewardship on the Length of Stay of Patients Admitted to Hospital With Pneumonia
Lead Sponsor:
Royal Victoria Hospital, Canada
Conditions:
Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the effectiveness of an antimicrobial stewardship program to reduce the length of stay of patients admitted to hospital with a diagnosis of pneumonia. The antimicrobial stewardshi...
Detailed Description
Antimicrobial stewardship is defined as any activity that promotes the appropriate selection, dosing, route and duration of antibiotic therapy. Antimicrobial stewardship programs usually include pharm...
Eligibility Criteria
Inclusion
- Community-acquired pneumonia
- Immunocompetent
- Age \> 18 years
Exclusion
- Admitted to an intensive care unit or high intensity unit
- Requiring invasive or non-invasive ventilation
- Life expectancy less than 3 months
- Hospitalization within the previous 3 months for at least 48 consecutive hours
- Immunocompromised defined as defined as having leukemia, lymphoma, HIV with CD4 count \<=200, splenectomy or on cytotoxic chemotherapy
- Neutropenic \[defined as a PMN count\<=0.5x109 cells/L\] from any cause
- Receiving immunosuppressants \[defined as \>=40 mg prednisone daily (or steroid equivalent) for \>=2 weeks preceding hospitalization OR any other immunosuppressant used for systemic illness OR to prevent transplant rejection
Key Trial Info
Start Date :
April 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT02276092
Start Date
April 1 2015
End Date
April 1 2017
Last Update
January 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Victoria Regional Health Centre
Barrie, Ontario, Canada, L4M6M2